NO872966L - PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS. - Google Patents

PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS.

Info

Publication number: NO872966L
Authority: NO; Norway
Prior art keywords: granulocyty; procedure; preparation; stimulating; preparations
Prior art date: 1986-07-18

Application number

NO872966A

Other languages

Norwegian (no)

Other versions

NO171828C (en

NO872966D0 (en

NO171828B (en

Inventor

Minoru Machida

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-18

Filing date

1987-07-16

Publication date

1988-01-19

1987-07-16 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1987-07-16 Publication of NO872966D0 publication Critical patent/NO872966D0/en

1988-01-19 Publication of NO872966L publication Critical patent/NO872966L/en

1993-02-01 Publication of NO171828B publication Critical patent/NO171828B/en

1993-05-12 Publication of NO171828C publication Critical patent/NO171828C/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO872966A 1986-07-18 1987-07-16 PROCEDURE FOR THE PREPARATION OF A STABILIZED PHARMACEUTICAL PREPARATION CONTAINING A GRANULOCYTIC COLONY STIMULATING FACTOR NO171828C (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP16948786		1986-07-18
JP16948986		1986-07-18
JP16948686		1986-07-18
JP16948886		1986-07-18

Publications (4)

Publication Number	Publication Date
NO872966D0 NO872966D0 (en)	1987-07-16
NO872966L true NO872966L (en)	1988-01-19
NO171828B NO171828B (en)	1993-02-01
NO171828C NO171828C (en)	1993-05-12

Family

ID=27474266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO872966A NO171828C (en)	1986-07-18	1987-07-16	PROCEDURE FOR THE PREPARATION OF A STABILIZED PHARMACEUTICAL PREPARATION CONTAINING A GRANULOCYTIC COLONY STIMULATING FACTOR

Country Status (24)

Country	Link
KR (1)	KR930004597B1 (en)
CN (1)	CN1033738C (en)
AT (1)	AT402259B (en)
AU (1)	AU611856B2 (en)
BE (1)	BE1000253A3 (en)
CA (1)	CA1297007C (en)
CH (1)	CH671157A5 (en)
DE (1)	DE3723781C2 (en)
DK (1)	DK171308B1 (en)
ES (1)	ES2010226A6 (en)
FR (1)	FR2601591B1 (en)
GB (1)	GB2193631B (en)
GR (1)	GR871067B (en)
HK (1)	HK64893A (en)
HU (1)	HU198627B (en)
IE (1)	IE60290B1 (en)
IL (1)	IL83220A (en)
IT (1)	IT1218927B (en)
NL (1)	NL192917C (en)
NO (1)	NO171828C (en)
PT (1)	PT85343B (en)
SE (1)	SE503312C2 (en)
SG (1)	SG64393G (en)
YU (1)	YU47543B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4929442A (en) *	1986-09-26	1990-05-29	Exovir, Inc.	Compositions suitable for human topical application including a growth factor and/or related materials
US4847325A (en) *	1988-01-20	1989-07-11	Cetus Corporation	Conjugation of polymer to colony stimulating factor-1
NZ228285A (en) *	1988-03-11	1991-08-27	Teikoku Seiyaku Kk	Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5981485A (en)	1997-07-14	1999-11-09	Genentech, Inc.	Human growth hormone aqueous formulation
US5349052A (en) *	1988-10-20	1994-09-20	Royal Free Hospital School Of Medicine	Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
GB8824591D0 (en)	1988-10-20	1988-11-23	Royal Free Hosp School Med	Fractionation process
US6132763A (en) *	1988-10-20	2000-10-17	Polymasc Pharmaceuticals Plc	Liposomes
US5104651A (en) *	1988-12-16	1992-04-14	Amgen Inc.	Stabilized hydrophobic protein formulations of g-csf
EP0459516A1 (en) *	1990-06-01	1991-12-04	Kirin-Amgen, Inc.	Oral dosage form of biologically active proteins
JP3249147B2 (en) *	1990-06-01	2002-01-21	キリン−アムジエン・インコーポレーテツド	Oral preparation containing bioactive protein
FR2686899B1 (en)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2686900B1 (en) *	1992-01-31	1995-07-21	Rhone Poulenc Rorer Sa	NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2693907B1 (en) *	1992-07-23	1994-09-02	Rhone Poulenc Rorer Sa	A method of administering granulocyte colony stimulating factor solutions.
EP0582932A1 (en) *	1992-08-11	1994-02-16	F. Hoffmann-La Roche Ag	Therapeutic system for the parenteral administration of hematopoietic growth factors
DE4242863A1 (en) *	1992-12-18	1994-06-23	Boehringer Mannheim Gmbh	Stable lyophilized pharmaceutical preparations of G-CSF
DE4242919A1 (en) *	1992-12-18	1994-06-23	Boehringer Mannheim Gmbh	Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
US20030053982A1 (en)	1994-09-26	2003-03-20	Kinstler Olaf B.	N-terminally chemically modified protein compositions and methods
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
ATE216590T1 (en) *	1995-02-06	2002-05-15	Genetics Inst	DRUG FORMULATIONS FOR IL-12
TW434021B (en) *	1995-03-15	2001-05-16	Kirin Brewery	Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
TW434020B (en) *	1995-03-15	2001-05-16	Kirin Brewery	Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
GB9526733D0 (en)	1995-12-30	1996-02-28	Delta Biotechnology Ltd	Fusion proteins
US20030190307A1 (en)	1996-12-24	2003-10-09	Biogen, Inc.	Stable liquid interferon formulations
KR100389726B1 (en) *	1998-03-06	2003-06-27	쥬가이 세이야쿠 가부시키가이샤	A stable granulocyte colony-stimulating factor-containing formulation
US6979442B1 (en) *	1998-08-17	2005-12-27	Pfizer Inc.	Stabilized protein compositions
DE60038386T2 (en)	1999-09-08	2009-04-23	Chugai Seiyaku K.K.	STABLE PROTEIN SOLUTION FILLED IN A RESERVOIR OF HYDROPHOBIC RESIN AND A METHOD FOR STABILIZING THE SAME
JP4683810B2 (en) *	2000-02-29	2011-05-18	中外製薬株式会社	Long-term stabilized preparation
ATE269716T1 (en) *	2000-02-29	2004-07-15	Pfizer Prod Inc	STABILIZED GRANULOCYTE COLONY- STIMULATING FACTOR
US6946134B1 (en)	2000-04-12	2005-09-20	Human Genome Sciences, Inc.	Albumin fusion proteins
EP2295456A1 (en)	2000-04-12	2011-03-16	Human Genome Sciences, Inc.	Albumin fusion proteins
KR20030027077A (en) *	2000-09-01	2003-04-03	쥬가이 세이야쿠 가부시키가이샤	Solution preparations stabilized over long time
US8435939B2 (en)	2000-09-05	2013-05-07	Biokine Therapeutics Ltd.	Polypeptide anti-HIV agent containing the same
US7507413B2 (en)	2001-04-12	2009-03-24	Human Genome Sciences, Inc.	Albumin fusion proteins
EP1463751B1 (en)	2001-12-21	2013-05-22	Human Genome Sciences, Inc.	Albumin fusion proteins
CA2537158C (en)	2002-08-27	2014-07-22	Hirokazu Tamamura	Cxcr4 antagonist and use thereof
WO2004075913A1 (en)	2003-02-28	2004-09-10	Chugai Seiyaku Kabushiki Kaisha	Stabilized preparation containing protein
DE102006009437A1 (en)	2006-03-01	2007-09-13	Bioceuticals Arzneimittel Ag	G-CSF liquid formulation
US8663651B2 (en)	2006-12-21	2014-03-04	Biokine Therapeutics Ltd.	T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation
WO2010092571A2 (en)	2009-02-11	2010-08-19	Yeda Research And Development Co. Ltd.	Short beta-defensin-derived peptides
AU2011207915B2 (en) *	2010-01-19	2013-07-11	Hanmi Science Co., Ltd.	Liquid formulations for long-acting G-CSF conjugate
EP2399572A1 (en)	2010-06-22	2011-12-28	Sandoz AG	Long-term storage of non-glycosylated recombinant human G-CSF
MX2017016844A (en)	2015-07-16	2018-08-15	Biokine Therapeutics Ltd	Compositions and methods for treating cancer.
BR112018016924A2 (en)	2016-02-23	2019-01-02	Biokine Therapeutics Ltd	treatment regimen selection method for individual who has acute myeloid leukemia (LMA), acute response myeloid leukemia (LMA) treatment maximization method, lma treatment method, cxcr4 antagonist, and chemotherapeutic agent in the treatment of lma
WO2018138267A1 (en)	2017-01-27	2018-08-02	Cinfa Biotech S.L.	Method for determining the efficacy of a g-csf containing composition
CN112512480B (en) *	2018-05-21	2024-10-01	中外制药株式会社	Freeze-dried preparation enclosed in glass container

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652636A1 (en) *	1976-11-19	1978-05-24	Hans Uwe Dr Rer Nat Wolf	Stabilising protein during separation, purification and storage - by adding amphiphilic cpds., esp. lipid(s), ionic and or nonionic detergents
AU523077B2 (en) *	1978-03-20	1982-07-08	Green Cross Corporation, The	Hgi glycoprotein
EP0098110B1 (en) *	1982-06-24	1989-10-18	NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD	Long-acting composition
JPS60228422A (en) *	1984-04-26	1985-11-13	Suntory Ltd	Stabilized preparation of physiologically active substance
JPS61227526A (en) *	1984-07-25	1986-10-09	Chugai Pharmaceut Co Ltd	Novel csf and method of collecting same
JPS6191131A (en) *	1984-10-09	1986-05-09	Chugai Pharmaceut Co Ltd	Method and composition for preventing adsorption of pharmaceutical
AU590543B2 (en) *	1985-02-05	1989-11-09	Albert Einstein College Of Medicine Of Yeshiva University	Purification of native colony stimulating factor-1
US4810643A (en) *	1985-08-23	1989-03-07	Kirin- Amgen Inc.	Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (en) *	1985-10-04	1994-03-16	中外製薬株式会社	Leukopenia treatment

1987
- 1987-07-08 GR GR871067A patent/GR871067B/en unknown
- 1987-07-10 IT IT67594/87A patent/IT1218927B/en active
- 1987-07-13 NL NL8701640A patent/NL192917C/en not_active IP Right Cessation
- 1987-07-14 AT AT0177587A patent/AT402259B/en not_active IP Right Cessation
- 1987-07-15 DK DK368387A patent/DK171308B1/en not_active IP Right Cessation
- 1987-07-15 AU AU75665/87A patent/AU611856B2/en not_active Expired
- 1987-07-15 BE BE8700787A patent/BE1000253A3/en not_active IP Right Cessation
- 1987-07-15 CA CA000542239A patent/CA1297007C/en not_active Expired - Lifetime
- 1987-07-16 NO NO872966A patent/NO171828C/en not_active IP Right Cessation
- 1987-07-16 PT PT85343A patent/PT85343B/en unknown
- 1987-07-16 CH CH2727/87A patent/CH671157A5/en not_active IP Right Cessation
- 1987-07-17 YU YU134287A patent/YU47543B/en unknown
- 1987-07-17 ES ES8702106A patent/ES2010226A6/en not_active Expired
- 1987-07-17 IE IE193387A patent/IE60290B1/en not_active IP Right Cessation
- 1987-07-17 SE SE8702907A patent/SE503312C2/en not_active IP Right Cessation
- 1987-07-17 HU HU873268A patent/HU198627B/en unknown
- 1987-07-17 DE DE3723781A patent/DE3723781C2/en not_active Expired - Lifetime
- 1987-07-17 GB GB8716904A patent/GB2193631B/en not_active Expired - Lifetime
- 1987-07-17 IL IL83220A patent/IL83220A/en not_active IP Right Cessation
- 1987-07-17 FR FR878710156A patent/FR2601591B1/en not_active Expired - Lifetime
- 1987-07-18 CN CN87104963A patent/CN1033738C/en not_active Expired - Lifetime
- 1987-07-18 KR KR1019870007804A patent/KR930004597B1/en not_active IP Right Cessation
1993
- 1993-05-18 SG SG64393A patent/SG64393G/en unknown
- 1993-07-08 HK HK648/93A patent/HK64893A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB2193631B (en)	1990-11-21
HU198627B (en)	1989-11-28
DE3723781A1 (en)	1988-01-21
NO171828C (en)	1993-05-12
CN1033738C (en)	1997-01-08
NL192917C (en)	1998-05-07
HUT44941A (en)	1988-05-30
AT402259B (en)	1997-03-25
IE871933L (en)	1988-01-18
DK368387A (en)	1988-01-19
HK64893A (en)	1993-07-16
CH671157A5 (en)	1989-08-15
DE3723781C2 (en)	1999-09-02
AU7566587A (en)	1988-01-21
NO872966D0 (en)	1987-07-16
DK368387D0 (en)	1987-07-15
PT85343B (en)	1990-04-30
YU47543B (en)	1995-10-03
SG64393G (en)	1993-08-06
GB2193631A (en)	1988-02-17
IL83220A0 (en)	1987-12-31
SE8702907D0 (en)	1987-07-17
AU611856B2 (en)	1991-06-27
ATA177587A (en)	1996-08-15
GB8716904D0 (en)	1987-08-26
KR930004597B1 (en)	1993-06-01
YU134287A (en)	1989-06-30
IT1218927B (en)	1990-04-24
PT85343A (en)	1987-08-01
IL83220A (en)	1993-01-31
NL192917B (en)	1998-01-05
IE60290B1 (en)	1994-06-29
NL8701640A (en)	1988-02-16
ES2010226A6 (en)	1989-11-01
SE503312C2 (en)	1996-05-13
GR871067B (en)	1987-11-19
KR880001297A (en)	1988-04-22
FR2601591A1 (en)	1988-01-22
NO171828B (en)	1993-02-01
IT8767594A0 (en)	1987-07-10
SE8702907L (en)	1988-01-19
BE1000253A3 (en)	1988-09-27
FR2601591B1 (en)	1991-04-26
CA1297007C (en)	1992-03-10
DK171308B1 (en)	1996-09-02
CN87104963A (en)	1988-02-24

Publication	Publication Date	Title
NO872966D0 (en)	1987-07-16	PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS.
NO875045L (en)	1988-06-06	PROCEDURE FOR THE PREPARATION OF TOPICAL PREPARATIONS FOR TREATMENT OF ACN.
NO875378L (en)	1988-06-24	PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING FACTOR (POLYPEPTID DERIVATIVES).
NO870579L (en)	1987-08-17	PROCEDURE FOR THE PREPARATION OF INDOLIZIN DERIVATIVES.
NO871266L (en)	1987-09-28	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES.
NO821198L (en)	1982-10-18	PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR THE TREATMENT OF MELANOMES.
NO167392C (en)	1991-10-30	PROCEDURE FOR THE PREPARATION OF IMIDAZOPYRIDINES.
NO171006C (en)	1993-01-13	PROCEDURE FOR THE MANUFACTURING OF ANTI-ANXIOUS PREPARATIONS
NO870526D0 (en)	1987-02-11	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES.
NO874869D0 (en)	1987-11-23	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO874032L (en)	1988-03-28	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES.
NO872712D0 (en)	1987-06-29	PROCEDURE FOR THE PREPARATION OF CALCIUM PREPARATIONS.
NO874467D0 (en)	1987-10-26	PROCEDURE FOR THE PREPARATION OF 3-PYRROLIDINOLS.
NO872551D0 (en)	1987-06-18	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO875488D0 (en)	1987-12-30	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKANSULPHONANILIDE DERIVATIVES.
NO874200L (en)	1988-04-11	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO874268L (en)	1988-04-15	PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED PIPERAZINONS.
NO871759L (en)	1987-11-02	PROCEDURE FOR THE PREPARATION OF SUCRAL BATH PREPARATIONS.
NO873400D0 (en)	1987-08-13	PROCEDURE FOR THE PREPARATION OF SULPHIDE-FREE ALKALIVESE.
NO875359D0 (en)	1987-12-21	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO872233D0 (en)	1987-05-27	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO873423D0 (en)	1987-08-14	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO872690D0 (en)	1987-06-26	PROCEDURE FOR THE PREPARATION OF MERCAPTOACYLPROLIN.
NO874199D0 (en)	1987-10-07	PROCEDURE FOR THE PREPARATION OF IMIDAZO-PYRIDINO DERIVATIVES.
NO871907D0 (en)	1987-05-07	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENAMIDE DERIVATIVES.

Legal Events

Date	Code	Title	Description
2007-08-27	MK1K	Patent expired